Citadel Advisors’s Milestone Scientific MLSS Stock Holding History

Citadel Advisors’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$466	–	14089
2025 Q1	$466	Buy	+500	New	+$549	﹤0.01%	14257
2024 Q1	–	Sell	-400	Closed	-$276	–	15146
2023 Q4	$276	Sell	400 -100	-20%	-$80	﹤0.01%	14067
2023 Q3	$460	Buy	+500	New	+$527	﹤0.01%	14047
2023 Q1	–	Sell	-2,200	Closed	-$1.06K	–	15185
2022 Q4	$1.06K	Buy	+2,200	New	+$1.42K	﹤0.01%	14531
2022 Q2	–	Sell	-12,100	Closed	-$18K	–	13638
2022 Q1	$18K	Buy	12,100 +600	+5%	+$876	﹤0.01%	13273
2021 Q4	$24K	Buy	+11,500	New	+$25.3K	﹤0.01%	13544
2021 Q3	–	Sell	-19,900	Closed	-$49K	–	14336
2021 Q2	$49K	Buy	+19,900	New	+$48.3K	﹤0.01%	13347

Other funds holding MLSS

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIA

World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

CIC

Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's MLSS Position: Q1 2026 in Review

Citadel Advisors increased its Milestone Scientific (MLSS) stake by 8.7% in Q1 2026, buying an estimated $3.73K and bringing the position to 167,135 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12417.

Citadel Advisors first reported a position in MLSS in Q1 2017 and has held it in 21 quarters since. The position peaked at $143K in Q2 2022. 32 funds tracked by Wall St. Rank hold MLSS as of Q1 2026.

Citadel Advisors held 167,135 shares of Milestone Scientific worth $48.1K as of Q1 2026.
Citadel Advisors bought 13,360 Milestone Scientific shares in Q1 2026, an estimated $3.73K.
Milestone Scientific made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12417 holding.
Citadel Advisors first reported a position in Milestone Scientific in Q1 2017 and has held it in 21 quarters since.
Citadel Advisors's Milestone Scientific position peaked at $143K in Q2 2022.
32 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.